767
Participants
Start Date
October 31, 2012
Primary Completion Date
February 29, 2016
Study Completion Date
February 29, 2016
EVP-6124
Arms 1, 2
Placebo
Arm 3
Phoenixville
Little Rock
Cerritos
Chino
Costa Mesa
Garden Grove
Glendale
Norwalk
Oakland
Oakland Park
Oceanside
Riverside
San Diego
San Gabriel
Santa Ana
Sherman Oaks
Washington D.C.
Bradenton
Miami
Miami Springs
North Miami
Orlando
Marietta
Smyrna
Chicago
Oak Brook
Oak Park
Wichita
Lake Charles
Shreveport
Rockville
Boston
Saint Charles
St Louis
Lincoln
Princeton
Jamaica
New York
Rochester
Charlotte
Beachwood
Oklahoma City
Jenkintown
Austin
Dallas
Salt Lake City
Bellevue
Richland
Spokane
Banfield
Caba
Mendoza
Rosario
Santiago del Estero
Adelaide
Mount Claremont
Salvader
Belo Horizonte
Curitiba
Medellín
Barranquilla
Pereira
Bogota D.C.
Florence
Milan
Ban
Barl
Catania
Lucca
Milan
Pisa
Roma
Monterrey
Mexico City
San Luis Potosí City
Bełchatów
Chełmno
Karakow
Kielce
Kotarbinskiego
Sosnowiec
Torun
Wroclaw
Campulung Muscel
Oradea
Cluj-Napoca
Palazu Mare
Iași
Târgu Mureş
Bucharest
Saint Petersburg
Smolensk
Moscow
Samara
Yaroslavl
Vil. Stepanivka
Dnipropetrovsk
Kharkiv
Kyiv
Lviv
Poltava
Vinnytsia
Cambridge
Newcastle upon Tyne
Exeter
London
Lead Sponsor
Collaborators (2)
Syneos Health
OTHER
NeuroCog Trials, Inc.
INDUSTRY
FORUM Pharmaceuticals Inc
INDUSTRY